Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein-L-isoaspartate O-methyltransferase domain containing 1 pseudogene 7 (PCMTD1P7) is a genomic pseudogene locus that shares sequence homology with the functional PCMTD1 gene, which encodes a domain found in protein-L-isoaspartate (D-aspartate) O-methyltransferases. PCMTD1P7 is classed as a processed pseudogene and is presumed noncoding—it does not encode a functional protein. Pseudogenes like PCMTD1P7 may occasionally produce RNA transcripts, but these do not have a known coding or regulatory function unless otherwise demonstrated. Unlike some pseudogenes (e.g., PTENP1, KRAS1P[1][2]), there is no published evidence that PCMTD1P7 acts as a regulatory RNA, microRNA decoy, or plays a role in disease pathogenesis. As such, it is not considered a therapeutic target. There is no evidence that this pseudogene is therapeutically actionable, disease-related, or studied as a receptor, enzyme, transporter, or transcription factor in drug development. If you are seeking information on the functional, protein-coding gene (such as PCMTD1 itself), please provide the specific gene name.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein-L-isoaspartate O-methyltransferase domain containing 1 pseudogene 7 (PCMTD1P7).